Fertility Preservation

If you will be receiving cancer treatment, this is the time to explore options for having children in the future. While infertility is a distressing side effect of many cancer treatments, The Fertility Preservation Program at the University of Michigan Health Systems gives you options for having the family you always wanted, or adding onto the family you already have.

Technician working with lab equipment

Freezing sperm or eggs prior to the initiation of cancer therapy gives patients diagnosed with cancer the potential to have a child in the future. Too often, this service is not considered until the patient is well into cancer treatment and by then, it may be too late. Through a multidisciplinary approach involving your oncology, urology and reproductive specialists, we provide counseling and education services to help you understand your options, as well as sperm and egg collection and storage service.

The Fertility Preservation Program (FP), provides counseling and education services, as well as semen collection and storage for male patients; and oocyte (egg) stimulation, harvesting and storage services for female patients. The FP aims to address the information needs regarding procedural, custody, legal and financial issues, and will assist the patient through the cryopreservation process in an efficient manner allowing for minimal delays in cancer treatment.

The Fertility Preservation Program provides patients:

  • Counseling to discuss cancer-related infertility issues
  • The expertise of the Assisted Reproduction Technology laboratory
  • Physician specialists in reproductive endocrinology
  • A nurse counselor, who acts as liaison between the laboratory and Cancer Center physicians, ensuring timely processing of samples
  • Comprehensive educational materials for patients, partners and family members

We also address the information needed regarding procedural, custody, legal and financial issues, and will assist you through the freezing process in an efficient manner, allowing for minimal delays in cancer treatment.